reports
Kimberly Clark Corp: 2 directors
Two Directors at Kimberly Clark Corp sold after exercising options/sold 16,466 shares at between 137.168USD and 137.250USD. The significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by a...
- ABGSC Renewable Energy Research
- Haakon Amundsen
- Stian Wibstad
- ABGSC Renewable Energy Research
- Haakon Amundsen
- Stian Wibstad
COTS Technology Co Ltd: 2 directors
Two Directors at COTS Technology Co Ltd sold 3,000 shares at between 25,250.000KRW and 25,750.000KRW. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's direc...
Equinor to commence second tranche of the 2024 share buy-back programm...
Equinor to commence second tranche of the 2024 share buy-back programme Equinor (OSE: EQNR, NYSE: EQNR) will after the annual general meeting 14 May 2024 commence the second tranche of up to USD 1.6 billion of the share buy-back programme for 2024, as announced in relation with the first quarter results 25 April 2024. Execution of share buy-back under this second tranche is subject to renewal of a board authorisation for share buy-back from the annual general meeting 14 May 2024 and agreement with the Norwegian State regarding share buy-back. In this second tranche of the share bu...
Equinor vil starte andre transje av tilbakekjøpsprogrammet for aksjer ...
Equinor vil starte andre transje av tilbakekjøpsprogrammet for aksjer for 2024 Equinor (OSE: EQNR, NYSE: EQNR) vil etter generalforsamlingen 14. mai 2024 starte andre transje av tilbakekjøpsprogrammet for aksjer for 2024 på inntil 1,6 milliarder USD, som annonsert i forbindelse med selskapets første kvartalsresultat 25. april 2024. Gjennomføring av tilbakekjøp i denne andre transjen er betinget av fornyet styrefullmakt fra generalforsamlingen den 14. mai 2024 og avtale med den norske stat om tilbakekjøp av aksjer. I denne andre transjen av tilbakekjøpsprogrammet for 2024 vil aksjer fo...
Equinor ASA: Key information relating to cash dividend for first quart...
Equinor ASA: Key information relating to cash dividend for first quarter 2024 Key information relating to the cash dividend to be paid by Equinor (OSE: EQNR, NYSE: EQNR) for first quarter 2024. Ordinary cash dividend amount: 0.35 Extraordinary cash dividend amount: 0.35 Announced currency: USD Last day including rights: 15 August 2024 Ex-date Oslo Børs: 16 August 2024 Ex-date New York Stock Exchange: 19 August 2024 Record date: 19 August 2024 Payment date: 28 August 2024 Date of approval: 24 April 2024 Other information: The cash dividend per share in NOK will be communicated 23 A...
Equinor ASA: Nøkkelinformasjon ved kontantutbytte for første kvartal 2...
Equinor ASA: Nøkkelinformasjon ved kontantutbytte for første kvartal 2024 Nøkkelinformasjon ved kontantutbytte for Equinor (OSE: EQNR, NYSE: EQNR) for første kvartal 2024. Ordinært utbyttebeløp: 0,35 Ekstraordinært utbyttebeløp: 0,35 Annonsert valuta: USD Siste dag inklusive: 15. august 2024 Ex-dato Oslo Børs: 16. august 2024 Ex-dato New York Stock Exchange: 19. august 2024 Record date (eierregisterdato): 19. august 2024 Betalingsdato: 28. august 2024 Vedtaksdato: 24. april 2024 Øvrig informasjon: Kontantutbytte i NOK per aksje vil bli kommunisert 23. august 2024. Denne informasj...
Equinor first quarter 2024 results
Equinor first quarter 2024 results Equinor (OSE: EQNR, NYSE: EQNR) delivered adjusted operating income* of USD 7.53 billion and USD 2.57 billion after tax in the first quarter of 2024. Equinor reported net operating income of USD 7.63 billion and net income at USD 2.67 billion. Adjusted net income* was USD 2.84 billion, leading to adjusted earnings per share* of USD 0.96. Financial and operational performance Strong operational performance and productionSolid financial results and cash flowHigh results from marketing and trading Strategic progress Power-from-shore to the Sleipne...
Equinors resultater for første kvartal 2024
Equinors resultater for første kvartal 2024 Equinor (OSE: EQNR, NYSE: EQNR) leverte et justert driftsresultat* på 7,53 milliarder USD, og 2,57 milliarder USD etter skatt i første kvartal 2024. Det rapporterte driftsresultatet var 7,63 milliarder USD, og resultatet for perioden var 2,67 milliarder USD. Justert resultat* var 2,84 milliarder USD, noe som ga et justert resultat per aksje* på 0,96 USD. Finansielle resultater og drift God drift og høy produksjonSolide finansielle resultater og kontantstrømSterke resultater fra tradingvirksomheten Strategisk framgang Kraft fra land til...
EQS-News: Redcare setzt starkes zweistelliges Wachstum in Q1 bei posit...
EQS-News: Redcare Pharmacy N.V. / Schlagwort(e): Zwischenbericht/Quartals-/Zwischenmitteilung Redcare setzt starkes zweistelliges Wachstum in Q1 bei positiver Marge von 2,1% fort. Durchbruch bei Online-E-Rx in Deutschland nach vielen Jahren ebenfalls in Q1. 25.04.2024 / 06:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Redcare setzt starkes zweistelliges Wachstum in Q1 bei positiver Marge von 2,1% fort. Durchbruch bei Online-E-Rx in Deutschland nach vielen Jahren ebenfalls in Q1. Konzernumsatz von EUR 560 Mio. in Q1, ein Plus vo...
EQS-News: Redcare’s fast double-digit growth continues in Q1, and at a...
EQS-News: Redcare Pharmacy N.V. / Key word(s): Interim Report/Quarterly / Interim Statement Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany. 25.04.2024 / 06:30 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany. Group sales of EUR 560M in Q1, up 51% from prior year. Non-Rx sales growth 20%...
EQS-News: SNP startet nach Rekordjahr 2023 mit dem besten ersten Quart...
EQS-News: SNP Schneider-Neureither & Partner SE / Schlagwort(e): Quartalsergebnis SNP startet nach Rekordjahr 2023 mit dem besten ersten Quartal der Unternehmensgeschichte 25.04.2024 / 06:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Corporate News SNP startet nach Rekordjahr 2023 mit dem besten ersten Quartal der Unternehmensgeschichte Konzernumsatz stieg im Q1 2024 um 15 % auf 54,0 Mio. € (Q1 2023: 47,1 Mio. €) EBIT kletterte deutlich um 63 % auf 4,0 Mio. € (Q1 2023: 2,5 Mio. €), EBIT-Marge auf 7,4 % (Q1 2023: 5,2 %) Deutl...
EQS-News: After Record Year 2023 SNP Starts with the Best First Quarte...
EQS-News: SNP Schneider-Neureither & Partner SE / Key word(s): Quarter Results After Record Year 2023 SNP Starts with the Best First Quarter Ever 25.04.2024 / 06:30 CET/CEST The issuer is solely responsible for the content of this announcement. Corporate News After Record Year 2023 SNP Starts with the Best First Quarter Ever Group revenue increased by 15% to €54.0 million in Q1 2024 (Q1 2023: €47.1 million) EBIT rose by 63% to €4.0 million (Q1 2023: €2.5 million), EBIT margin to 7.4% (Q1 2023: 5.2%) Operating cashflow turned significantly positive, totaling to €10.3 ...
Hashicorp Inc: 2 directors
Two Directors at Hashicorp Inc sold/sold after exercising options 40,904 shares at between 24.311USD and 26.385USD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the c...
Schwab Charles Corp: 2 directors
Two Directors at Schwab Charles Corp sold after exercising options/gave away/sold 130,925 shares at between 0.000USD and 74.616USD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary tra...
Mission Produce Inc: 1 director
A director at Mission Produce Inc sold 101,203 shares at 11.341USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Salesforce Inc: 7 directors
Seven Directors at Salesforce Inc sold after exercising options/sold/gave away 56,229 shares at between 0.000USD and 279.100USD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades...
Primeenergy Resources Corp: 1 director
A director at Primeenergy Resources Corp sold 4,558 shares at 100.023USD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Palomar Holdings Inc: 1 director
A director at Palomar Holdings Inc sold 7,000 shares at 80.034USD and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.